ApoB Discordance with LDL-C and Coronary Artery Calcium in the Multi-Ethnic Study of Atherosclerosis

This MESA (Multi-Ethnic Study of Atherosclerosis) analysis examined 4,623 participants to evaluate whether ApoB discordance from LDL-C predicted coronary artery calcium (CAC) score and extent beyond what either marker predicted alone.

In participants where ApoB indicated higher risk than LDL-C (elevated ApoB relative to LDL-C), CAC scores were higher than in concordant participants — indicating that elevated particle number beyond cholesterol content predicted greater subclinical coronary atherosclerosis burden. The excess CAC was concentrated in the discordant group: participants with high ApoB and normal LDL-C carried more coronary calcium than their LDL-C would suggest.

The CAC endpoint is particularly informative here because it is a direct anatomical measure of subclinical coronary atherosclerosis accumulation — not a surrogate biomarker. ApoB discordance’s association with excess CAC provides structural validation that elevated ApoB with normal LDL-C corresponds to real coronary plaque burden that LDL-C-based risk assessment would miss.

The relatively modest clinical significance rating reflects the study’s cross-sectional CAC endpoint: it establishes that discordant patients have more plaque than expected, but the direct link to future cardiovascular events from this specific analysis requires longitudinal outcome data (available from MESA’s follow-up studies).

We rate the evidence strong-moderate. A well-powered MESA prospective cohort analysis demonstrating that ApoB discordance from LDL-C is associated with excess coronary artery calcium — providing structural anatomical evidence that elevated ApoB at normal LDL-C corresponds to real subclinical coronary atherosclerosis burden.